Firms
Theme

AZO

AutoZone, Inc. · NYSE

News

9 latest

Zacks Investment Research

AutoZone (AZO) Suffers a Larger Drop Than the General Market: Key Insights

AutoZone stock declined 2.14% on October 23, 2026, underperforming the S&P 500's 0.52% loss. Despite a strong 14.29% monthly gain, the stock faces headwinds with a 1.49% decrease in consensus EPS estimates over the past 30 days.

Zacks Investment Research

Here is What to Know Beyond Why AutoZone, Inc. (AZO) is a Trending Stock

AutoZone (AZO) has gained 14.3% over the past month, outperforming the S&P 500. The company is expected to report 12.4% year-over-year earnings growth for the current fiscal year with 7.5% revenue growth. However, earnings estimates have declined slightly over the past month, resulting in a Zacks Rank #3 (Hold) rating, suggesting the stock may perform in line with the broader market in the near term.

Zacks Investment Research

AutoZone (AZO) Up 11% Since Last Earnings Report: Can It Continue?

AutoZone reported Q4 fiscal 2026 EPS of $56.05, beating consensus estimates by 2.8%, driven by gross margin expansion. However, net sales missed expectations at $6.60 billion.

Zacks Investment Research

AutoZone (AZO) Advances While Market Declines: Some Information for Investors

AutoZone stock gained 1.88% to $3,117.14, outperforming the broader market decline. The company is expected to report a 17.3% EPS increase and 7.01% revenue growth in the upcoming quarter. However, the Zacks Consensus EPS estimate has declined 2.26% in the past month, and the stock holds a Zacks Rank of #3 (Hold) with a Forward P/E ratio slightly above industry average.

Zacks Investment Research

Is Trending Stock AutoZone, Inc. (AZO) a Buy Now?

AutoZone has been a highly searched stock on Zacks.com. The company is expected to report 17.3% year-over-year earnings growth for the current quarter, with full-year earnings projected at +12.4%.

Zacks Investment Research

Is Most-Watched Stock AutoZone, Inc. (AZO) Worth Betting on Now?

AutoZone (AZO) has declined 2.6% over the past month, underperforming the S&P 500's 1% gain. Despite near-term weakness, the company shows strong fundamentals with expected earnings growth of 20.5% for the current quarter and 13.4% for the fiscal year.

Mentions AZO

The Motley Fool

Advance Auto Parts vs. Coupang: Which Stock Is a Better Buy in 2026?

The article compares Advance Auto Parts (AAP) and Coupang (CPNG) as investment options for 2026. Advance Auto Parts is undergoing a domestic turnaround with recent positive signs including positive free cash flow and margin expansion, though revenue missed expectations.

The Motley Fool

Advance Auto Parts vs. Uber Technologies: Fix the Car or Ride in It? Which Stock Is a Better Buy in 2026?

The article compares Advance Auto Parts and Uber Technologies as investment options. Advance Auto Parts, trading at a discount with a P/S ratio of 0.3x, faces challenges including negative free cash flow of -$298M, high debt-to-equity of 2.4x, and declining revenue, though management's turnaround program shows mixed results.

The Motley Fool

Advance Auto Parts vs. Airbnb: Which Consumer Stock Is a Better Buy in 2026?

The article compares Advance Auto Parts (AAP) and Airbnb (ABNB) as consumer stock investments. AAP trades at a deep discount while undergoing restructuring with mixed results, facing headwinds from weak DIY demand and competition.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $AZO · 0 threads

Sign in to post on $AZO

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev